Limited Stage Small Cell Lung Cancer Clinical Trials in Taiyuan, Shanxi
2 recruitingTaiyuan, Shanxi, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
Small Cell Lung CancerLimited Stage Small Cell Lung Cancer
Amgen400 enrolled204 locationsNCT06117774
Recruiting
Phase 2
Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients
Limited Stage Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences55 enrolled2 locationsNCT05443646